Comparison of the world health organization model essential medicines list and twenty-five national essential medicines lists: what can developing countries and the world health organization learn from one another about selection of medicines?
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: WANING, Brenda (Boston University, Center for Internationql Health, Boston, United States of America)
Aims: Evaluate the process of creating Essential Medicines Lists (EMLs) by the Expert Committee at the World Health Organization (WHO) and national selection committees in developing countries to identify trends, research priorities, and areas of improvement inselection of medicines. Methods: All WHO Model EMLs from 1977-2003 were.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.